Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
P
335810
vs
K
KOSPI 200
Over the past 12 months, Precision Biosensor Inc has underperformed KOSPI 200, delivering a return of -51% compared to KOSPI 200's +50% growth.
Stocks Performance
335810 vs KOSPI 200
Performance Gap
335810 vs KOSPI 200
Performance By Year
335810 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Precision Biosensor Inc
Glance View
Precision Biosensor Inc. makes diagnostic test products that help doctors and labs detect disease markers from blood or other samples. Its business centers on biosensor-based in vitro diagnostic kits and related testing systems, which are used for point-of-care testing and clinical lab work. The company sells these products to hospitals, clinics, laboratories, and other healthcare customers that need fast, reliable test results. The company makes money by selling test kits, reagents, and diagnostic devices, and in some cases by supporting the systems that run those tests. Its role in the healthcare value chain is between medical research and everyday patient care: it turns biological signals into practical tests that doctors can use quickly. That makes its business different from a drug maker, because it earns from repeat diagnostic use rather than from one-time treatments.